Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder

PHASE3CompletedINTERVENTIONAL
Enrollment

441

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

solifenacin succinate

Oral

Trial Locations (104)

10021

New York

11235

Brooklyn

11530

Garden City

11706

Bay Shore

12205

Albany

12206

Albany

12208

Albany

14092

Lewiston

14221

Williamsville

15146

Monroeville

15213

Pittsburgh

18015

Bethlehem

18103

Allentown

18760

Sellersville

19063

Media

19104

Philadelphia

19115

Philadelphia

19146

Philadelphia

19406

Charleston

20017

Washington D.C.

21117

Garrison

21204

Baltimore

22304

Alexandria

23294

Richmond

25701

Huntington

27511

Cary

28025

Concord

28601

Hickory

29425

Charleston

29572

Myrtle Beach

29801

Aiken

30005

Alpharetta

30342

Atlanta

30513

Blue Ridge

32086

Saint Augustine

32114

Daytona Beach

32308

Tallahassee

32607

Gainesville

32763

Orange City

32803

Orlando

33063

Margate

33180

Aventura

33761

Clearwater

33765

Clearwater

34652

New Port Richey

37760

Jefferson City

44195

Cleveland

45212

Cincinnati

45220

Cincinnati

46202

Indianapolis

47130

Jeffersonville

47303

Muncie

47714

Evansville

53717

Madison

60616

Chicago

60714

Niles

60901

Kankakee

62801

Centralia

63117

St Louis

63141

St Louis

72211

Little Rock

73008

Bethany

74136

Tulsa

75010

Carrollton

75751

Athens

76017

Arlington

77024

Houston

78238

San Antonio

80012

Aurora

80205

Denver

80220

Denver

83702

Boise

83814

Coeur d'Alene

84010

Bountiful

84041

Layton

84403

Ogden

85032

Phoenix

85258

Scottsdale

87108

Albuquerque

89109

Las Vegas

90017

Los Angeles

90048

Los Angeles

90057

Los Angeles

90505

Torrance

91345

Mission Hills

91607

Valley Village

91741

Glendora

91786

Upland

91942

La Mesa

92404

San Bernadino

93618

Dinuba

95350

Modesto

97411

Springfield

98111

Seattle

99202

Spokane

99508

Anchorage

06302

Farmington

06850

Norwalk

06611

Trumbull

06708

Waterbury

08837

Edison

08648

Lawrenceville

07753

Neptune City

07052

West Orange

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00454740 - Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder | Biotech Hunter | Biotech Hunter